World News

Haia objects to feminization of pharmacies


The Commission for the Promotion of Virtue and Prevention of Vice (Haia) is opposing the feminization of pharmacies, the Jeddah Chamber of Commerce and Industry (JCCI) confirmed. Haia has objected even if there are barriers between men and women in the shop, and despite pharmacies in malls employing women, Ibrahim …

Read More »

FDA grants Breakthrough Therapy for ocrelizumab in multiple sclerosis


Roche announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the investigational medicine ocrelizumab (OCREVUSTM) for the treatment of people with primary progressive multiple sclerosis (PPMS). There are currently no approved treatments for PPMS, a debilitating form of MS characterised by steadily worsening …

Read More »

$1 billion dollar drug bust in Australia


(Rajon Pandit): Australian police discovered millions of dollars worth of drugs hidden inside a shipment of bras, part of what they said Monday was the country’s biggest ever liquid methamphetamine bust. Officers found more than Aus$1 billion (US$712 million) of the lethally-addictive drug — also known as ice — in …

Read More »

Bharat Biotech develops world’s first Zika vaccine


Hyderabad-based Bharat Biotech has filed for global patent of two vaccine candidates – a recombinant vaccine and an inactivated vaccine – for Zika virus. The company announced that it could make available the inactivated vaccine in two years if the Indian Government fast-tracked the regulatory approvals once the pre-clinical trials proved to be successful. Addressing a press conference here on …

Read More »

Sanofi provides key support to the Human Vaccines Project


Sanofi Pasteur, the vaccines division of Sanofi, has signed an agreement with the Human Vaccines Project Inc. to partially fund the non-profit, public-private partnership convening leading academic researchers and industrial partners to solve the primary problems impeding vaccine/immunotherapy development by “decoding” the human immune system. The Project is a global …

Read More »

Novartis continues to grow immuno-oncology pipeline through collaboration and licensing agreement with Surface Oncology


Novartis has announced that it is adding to its diverse and deep immuno-oncology pipeline through a strategic alliance and licensing agreement with Surface Oncology. The agreement gives Novartis access to four pre-clinical programs that target regulatory T cell populations, inhibitory cytokines, and immunosuppressive metabolites in the tumor microenvironment. These programs …

Read More »

5 Drugs Actually Decreased in Price Last Year in USA


Not every drug saw a price increase in 2015, despite widespread media coverage suggesting otherwise. Much of the national drug pricing debate last year centered on steep cost increases, including Daraprim’s infamous 5000% overnight price hike under former Turing Pharmaceuticals CEO Martin Shkreli. Adding to this fervor was an announcement …

Read More »

Chinese medicinal herbs provide niche market for US farmers


Expanding interest in traditional Chinese medicine in the United States is fostering a potentially lucrative new niche market for farmers who plant the varieties of herbs, flowers and trees sought by practitioners. While almost all practitioners still rely on imports from China, dwindling wild stands there, as well as quality …

Read More »

India pharma investors think small as US compliance woes hit big ones


Investors in India’s $15 billion pharmaceutical industry are favouring smaller firms with little or no exposure to the United States, where increasingly tight regulatory controls have burnt two of the country’s biggest drugmakers over the past month. Heavyweight generics makers, led by Sun Pharma and Dr Reddy’s Laboratories, have long …

Read More »

HIV pill price cut by half in US


The company that sparked an outcry by raising the price of its HIV drug in the US by 5,000% says it will cut its price for some users. Martin Shkreli’s drug company Turing Pharmaceuticals bought the rights to 62-year old drug Daraprim and increased the price per pill from $13.50 …

Read More »

Pfizer to buy Allergan in $160 billion deal


Pfizer Inc, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan Plc in a transaction valued at about $160 billion. The complex deal – the biggest ever in the healthcare sector – will allow Pfizer to shift its legal base to Ireland in a so-called …

Read More »